Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Baxter
Healthtrust
McKinsey
UBS
Dow
AstraZeneca
QuintilesIMS
Daiichi Sankyo
Teva

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076300

« Back to Dashboard

NDA 076300 describes FLUTICASONE PROPIONATE, which is a drug marketed by Fougera Pharms, G And W Labs, Nesher Pharms, Perrigo New York, Tolmar, Glenmark Generics, Perrigo Israel, Taro Pharm Inds, Apotex Inc, Hi Tech Pharma, West-ward Pharms Int, and Wockhardt, and is included in seventeen NDAs. It is available from seventy-four suppliers. Additional details are available on the FLUTICASONE PROPIONATE profile page.

The generic ingredient in FLUTICASONE PROPIONATE is fluticasone propionate. There are twenty-six drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 076300
Pharmacology for NDA: 076300
Suppliers and Packaging for NDA: 076300
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUTICASONE PROPIONATE fluticasone propionate OINTMENT;TOPICAL 076300 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0333 0168-0333-60 60 g in 1 TUBE (0168-0333-60)
FLUTICASONE PROPIONATE fluticasone propionate OINTMENT;TOPICAL 076300 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0333 0168-0333-15 15 g in 1 TUBE (0168-0333-15)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.005%
Approval Date:May 14, 2004TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Novartis
Fuji
Julphar
Cerilliant
Moodys
Accenture
Colorcon
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot